|
|
|
Insider
Information: |
Wang Lai |
Relationship: |
Global Head of R&D |
City: |
Camana Bay, Grand Cayman |
State: |
E9 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
1,724,697 |
|
Indirect Shares
|
58,188 |
|
|
Direct
Value |
$340,248,224 |
|
|
Indirect Value
|
$11,479,329 |
|
|
Total
Shares |
1,782,885 |
|
|
Total
Value |
$351,727,553 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Beigene Ltd |
BGNE |
Global Head of R&D |
2024-06-24 |
1,724,697 |
2024-06-24 |
58,188 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-06-28 |
4 |
S |
$362.48 |
$164,930 |
D/D |
(455) |
0 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-06-07 |
4 |
S |
$354.26 |
$232,392 |
D/D |
(656) |
0 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-06-18 |
4 |
S |
$331.15 |
$265,583 |
D/D |
(802) |
0 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2023-06-07 |
4 |
S |
$223.23 |
$103,828 |
D/D |
(462) |
0 |
0 |
% |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2023-06-26 |
4 |
S |
$181.91 |
$201,567 |
D/D |
(1,108) |
0 |
0 |
% |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2022-06-27 |
4 |
S |
$177.32 |
$81,215 |
D/D |
(458) |
0 |
0 |
% |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2024-06-24 |
4 |
S |
$159.80 |
$170,030 |
D/D |
(1,064) |
0 |
0 |
% |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2024-06-17 |
4 |
S |
$158.50 |
$238,857 |
D/D |
(1,500) |
841 |
0 |
% |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2024-06-18 |
4 |
S |
$153.75 |
$129,305 |
D/D |
(841) |
0 |
0 |
% |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2022-06-21 |
4 |
S |
$149.01 |
$107,734 |
D/D |
(723) |
0 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2022-06-06 |
4 |
S |
$142.00 |
$93,718 |
D/D |
(660) |
0 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2022-06-17 |
4 |
S |
$139.40 |
$62,034 |
D/D |
(445) |
723 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-12-15 |
4 |
A |
$30.13 |
$0 |
I/I |
0 |
0 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2022-05-17 |
4 |
OE |
$2.29 |
$4,025,737 |
D/D |
1,233,947 |
1,408,498 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
53,625 |
238,654 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-09-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
58,188 |
174,551 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-10-31 |
4 |
GD |
$0.00 |
$0 |
I/I |
58,188 |
0 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2021-10-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
58,188 |
58,188 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
125,255 |
1,509,989 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&D |
|
2024-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
168,935 |
1,768,962 |
0 |
- |
|
BGNE |
Beigene Ltd |
Global Head of R&DOfficer |
|
2021-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
203,983 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|